Special Episode, Part 2: COVID-19 - How Close Are We to a Vaccine?
In the second of a special two-part episode, we talk with biotech equity analyst Matthew Harrison about market response to new data in the race for a vaccine.
24 Heinä 20208min
Special Episode: COVID-19 - Preparing for Fall's Second Wave
In the first of a special two part episode, we talk with biotech equity analyst Matthew Harrison about new case projections ahead of fall and flu season.
23 Heinä 20208min
Michael Zezas: States Look to D.C. to Fill Budget Holes
Local and state governments across the U.S. are eagerly watching whether a new round of stimulus will help them address budget shortfalls. Will Congress deliver?
22 Heinä 20202min
Mike Wilson: Adapting to The Ninth Wonder of the World
Understanding the regime of financial repression we are under, and recent changes in it, is key for successful investment. Chief Investment Officer, Mike Wilson explains.
20 Heinä 20204min
Andrew Sheets: Bracing for Challenges Ahead
While July contains a number of potentially positive market events, August and September could present a number of potentially problematic ones.
17 Heinä 20203min
Michael Zezas: Coronavirus - Why Another Stimulus Deal is Likely
Could a new $1 trillion stimulus deal make its way through the halls of Congress before the summer recess? Why the likelihood of a deal is increasing.
15 Heinä 20202min
Mike Wilson: U.S. Markets Weigh Optimism; Uncertainty
U.S. equities—tech stocks in particular—have powered higher since March lows, but investors are still parsing Q2 earnings, a coming election and rising COVID-19 cases.
13 Heinä 20204min
Andrew Sheets: Pressure Testing the “Overoptimistic Markets” Argument
The sharp rebound in stock and corporate bond markets has made some question if markets are a bit too upbeat about a speedy recovery. There’s just one problem with this view.
10 Heinä 20203min
